Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda

Clicks: 400
ID: 110875
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Rotavirus vaccine is effective in preventing rotavirus disease in Rwandan children who began their rotavirus vaccine series from 7 to 18 weeks of age. Protection from vaccination was sustained after the first year of life.
Reference Key
je2016clinicaleffectiveness Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tate JE;Ngabo F;Donnen P;Gatera M;Uwimana J;Rugambwa C;Mwenda JM;Parashar UD;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2016
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/27059358
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't female male Infant P.H.S. Evaluation Study Diarrhea / epidemiology diarrhea / prevention & control* case-control studies gastroenteritis / virology immunization programs* rotavirus infections / prevention & control* rotavirus infections / virology rotavirus vaccines / immunology* vaccine potency vaccines attenuated / administration & dosage attenuated / immunology odds ratio pmid:27059358 doi:10.1093/cid/civ1016 jacqueline e tate fidele ngabo umesh d parashar africa south of the sahara / epidemiology diarrhea / virology gastroenteritis / epidemiology gastroenteritis / prevention & control* rotavirus / immunology rotavirus infections / epidemiology* rotavirus vaccines / administration & dosage* rwanda vaccination / statistics & numerical data vaccination / trends

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.